Search research articles
Contact Us
Filters
Showing results (391-400 of 426) with videos related to
Page
of 43
Sort By:
Blood Advances
|
August 19, 2022
Therapeutic targeting of PRAME with mTCRCAR T cells in acute myeloid leukemia
Danielle C Kirkey, Anisha M Loeb, Sommer Castro, et al.
Cancer Cell
|
February 28, 2025
Metabolic engineering to facilitate anti-tumor immunity
Tanya Schild, Patrick Wallisch, Yixuan Zhao, et al.
Science Translational Medicine
|
March 15, 2013
Targeting the intracellular WT1 oncogene product with a therapeutic human antibody
Tao Dao, Su Yan, Nicholas Veomett, et al.
Nature Biotechnology
|
September 22, 2015
Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1
Tao Dao, Dmitry Pankov, Andrew Scott, et al.
Nature Chemical Biology
|
December 31, 2021
Engineering CAR-T cells to activate small-molecule drugs in situ
Thomas J Gardner, J Peter Lee, Christopher M Bourne, et al.
Arthritis and Rheumatism
|
January 26, 2012
Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus
William Stohl, Falk Hiepe, Kevin M Latinis, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
February 5, 2020
A Genomic Profile of Local Immunity in the Melanoma Microenvironment Following Treatment with α Particle-Emitting Ultrasmall Silica Nanoparticles
Aleksandra M Urbanska, Raya Khanin, Simone Alidori, et al.
Blood
|
December 4, 2023
A dual-receptor T-cell platform with Ab-TCR and costimulatory receptor achieves specificity and potency against AML
Tao Dao, Guangyan Xiong, Sung Soo Mun, et al.
Science (New York, N.Y.)
|
July 24, 2025
Design of high-specificity binders for peptide-MHC-I complexes
Bingxu Liu, Nathan F Greenwood, Julia E Bonzanini, et al.
Blood
|
April 15, 2022
A TCR mimic CAR T cell specific for NDC80 is broadly reactive with solid tumors and hematologic malignancies
Martin G Klatt, Tao Dao, Zhiyuan Yang, et al.
Page
of 43
Search research articles
Search
Showing results (391-400 of 426) with videos related to
Sort By:
Page
of 43
Blood Advances
|
August 19, 2022
Therapeutic targeting of PRAME with mTCRCAR T cells in acute myeloid leukemia
Danielle C Kirkey, Anisha M Loeb, Sommer Castro, et al.
Cancer Cell
|
February 28, 2025
Metabolic engineering to facilitate anti-tumor immunity
Tanya Schild, Patrick Wallisch, Yixuan Zhao, et al.
Science Translational Medicine
|
March 15, 2013
Targeting the intracellular WT1 oncogene product with a therapeutic human antibody
Tao Dao, Su Yan, Nicholas Veomett, et al.
Nature Biotechnology
|
September 22, 2015
Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1
Tao Dao, Dmitry Pankov, Andrew Scott, et al.
Nature Chemical Biology
|
December 31, 2021
Engineering CAR-T cells to activate small-molecule drugs in situ
Thomas J Gardner, J Peter Lee, Christopher M Bourne, et al.
Arthritis and Rheumatism
|
January 26, 2012
Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus
William Stohl, Falk Hiepe, Kevin M Latinis, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
February 5, 2020
A Genomic Profile of Local Immunity in the Melanoma Microenvironment Following Treatment with α Particle-Emitting Ultrasmall Silica Nanoparticles
Aleksandra M Urbanska, Raya Khanin, Simone Alidori, et al.
Blood
|
December 4, 2023
A dual-receptor T-cell platform with Ab-TCR and costimulatory receptor achieves specificity and potency against AML
Tao Dao, Guangyan Xiong, Sung Soo Mun, et al.
Science (New York, N.Y.)
|
July 24, 2025
Design of high-specificity binders for peptide-MHC-I complexes
Bingxu Liu, Nathan F Greenwood, Julia E Bonzanini, et al.
Blood
|
April 15, 2022
A TCR mimic CAR T cell specific for NDC80 is broadly reactive with solid tumors and hematologic malignancies
Martin G Klatt, Tao Dao, Zhiyuan Yang, et al.
Page
of 43